Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schenk

Showing results (361-370 of 5,503) with videos related to

Pageof 551
Sort By:
Hospital Case Management : the Monthly Update on Hospital-Based Care Planning and Critical Paths|April 4, 2008
Web site links to valued post-discharge resourcesKaren Barbato, Molly Schenk
Best Practice & Research. Clinical Gastroenterology|May 22, 2008
The mucosal immune system at the gastrointestinal barrierMirjam Schenk, Christoph Mueller
Pharmacology, Biochemistry, and Behavior|August 31, 2001
Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behaviorS Schenk, B Partridge
Experimental Brain Research|March 13, 2001
Is writer's cramp caused by a deficit of sensorimotor integration?T Schenk, N Mai
Experimental Brain Research|September 4, 1999
Time constraints improve reaching movements in an ataxic patientT Schenk, N Mai
Lancet (London, England)|March 28, 2003
The COOPERATE trialJutta Halbekath, Stefanie Schenk
Behavioral Neuroscience|June 14, 2003
Olfactory and/or visual cues for spatial navigation through ontogeny: olfactory cues enable the use of visual cuesJérôme Rossier, Françoise Schenk
Oncotarget|February 19, 2019
CDK4/6 inhibition alone and in combination for non-small cell lung cancerJose Pacheco, Erin Schenk
Progress in Clinical and Biological Research|January 1, 1990
Prolonged mu- and delta-receptor occupancy may result in naloxone-reversible respiratory depression and naloxone-irreversible antinociceptionE Freye, G Schenk
Journal of Forensic Sciences|May 24, 2019
Fatality of 33-Year-Old Man Involving Kratom ToxicityMarcus Matson, Noel Schenk
Pageof 551

Showing results (361-370 of 5,503) with videos related to

Sort By:
Pageof 551
Hospital Case Management : the Monthly Update on Hospital-Based Care Planning and Critical Paths|April 4, 2008
Web site links to valued post-discharge resourcesKaren Barbato, Molly Schenk
Best Practice & Research. Clinical Gastroenterology|May 22, 2008
The mucosal immune system at the gastrointestinal barrierMirjam Schenk, Christoph Mueller
Pharmacology, Biochemistry, and Behavior|August 31, 2001
Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behaviorS Schenk, B Partridge
Experimental Brain Research|March 13, 2001
Is writer's cramp caused by a deficit of sensorimotor integration?T Schenk, N Mai
Experimental Brain Research|September 4, 1999
Time constraints improve reaching movements in an ataxic patientT Schenk, N Mai
Lancet (London, England)|March 28, 2003
The COOPERATE trialJutta Halbekath, Stefanie Schenk
Behavioral Neuroscience|June 14, 2003
Olfactory and/or visual cues for spatial navigation through ontogeny: olfactory cues enable the use of visual cuesJérôme Rossier, Françoise Schenk
Oncotarget|February 19, 2019
CDK4/6 inhibition alone and in combination for non-small cell lung cancerJose Pacheco, Erin Schenk
Progress in Clinical and Biological Research|January 1, 1990
Prolonged mu- and delta-receptor occupancy may result in naloxone-reversible respiratory depression and naloxone-irreversible antinociceptionE Freye, G Schenk
Journal of Forensic Sciences|May 24, 2019
Fatality of 33-Year-Old Man Involving Kratom ToxicityMarcus Matson, Noel Schenk
Pageof 551